Related to CSL to Use PharmaJet Needle-Free Injector for Flu Vaccine

• ZyGEM and Phthisis Diagnostics to Develop Tools to Detect Infectious Pathogens
  
• BD to Acquire HandyLab for Molecular Diagnostic Automation Platform
  
• FDA Approves AdvanDx’ Faster PNA FISH Protocol for Identifying Enterococcal Bloodstream Pathogens
  
• Biosearch Grants Micronics Rights to Its Nucleic Acid Assay Chemistries
  
• Investigators Propose Explanation for Flu Virus Antigenic Drift
  
• Pulmatrix to Pocket $32.4M to Accelerate Work in Respiratory Diseases
  
• Crucell Taps Calmune for Discovery Work in Infectious Diseases
  
• Genzyme to Evaluate to-BBB’s Technology for Delivering Biologics to the Brain
  
• Novartis to Buy 85% of Chinese Vaccines Company for $125M
  
• Pharmsynthez and Lipoxen Ink Vaccine- and Drug-Delivery Partnership
  
• Novartis’ Swine Flu Vaccine Effective at Half the Current Antigen Dose
  
• PPD and Janssen Ally on Therapies for Irritable Bowel Syndrome and Bacterial Infections
  
• Researchers Reveal Major Differences between Current H1N1 Strain and Other Recent Flu Strains
  
• Novartis Inaugurates $1B U.S. Cell Culture Flu Vaccine Facility
  
• Good and Bad News at Idera
  
• Sanofi-Aventis Licenses Intelliject’s Epinephrine Auto-Injector for $25M Up Front
  
• Akonni Wins $3.2M Grant to Develop Test for Detecting Different Flu Strains
  
• BTG Grants Allergan Rights to Gel-Based Drug-Delivery Technology for Use in Ocular Disease Treatment
  
• Seattle Genetics Receives $12M Up Front in Deal with GSK
  
• Aura to Use CRT's Cancer-Targeting Peptides for Delivery